XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.
about
Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapyA functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene.Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies.Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients.RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLCAllele and genotype distributions of DNA repair gene polymorphisms in South Indian healthy population.Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysisXPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies.Single nucleotide polymorphisms in DNA repair genes and putative cancer risk.Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Chinese C allele carriers of the ERCC5 rs1047768 polymorphism are more sensitive to platinum-based chemotherapy: a meta-analysis.
P2860
Q33572407-A5537F11-FD66-46D6-A074-ACD137B114DAQ33701903-7AB362FC-733A-48E0-A9B7-FA2971B5A4A5Q33733507-949EEBE3-C9BB-40ED-A823-4B5E4CB7C410Q33752840-30C8AB2E-F135-4DAE-B156-3982EC567232Q33781302-0022499D-05DE-4F35-A167-D1D26C2C5020Q33912148-B47E8C0E-5B95-4A26-A4B4-F737C8469431Q34002516-F2A549D5-54F0-488C-A455-6A824F3DC2D5Q34236406-2E1B698D-E9C4-4025-BD88-DDF76760CC6FQ34325669-72B5A2F4-7DBB-416F-877C-2A4979261676Q34446751-14B9ABEB-A4BC-4C60-B050-02CA827E393DQ34657153-A6E54108-E1FB-4438-9417-240919FF1E18Q34686858-F27CAD34-4ED0-4B08-ADC6-B9F219C7F14CQ36375374-159A67B3-2328-4567-BDA5-6CE2DC7A37A6Q37688309-76FE8C1A-5425-4180-80B9-185D95B1B73EQ38372127-67C694AB-B126-464A-B5FE-45B32F8D6E3BQ38873757-5E9726F9-4612-4DE6-BD15-986BBE50C940Q38909984-C40D61F3-CCE4-4F88-833D-629EDEFB2C4CQ38953629-2A7AB59B-B721-422F-8E45-63236D8CBC7FQ49359901-02942F03-405E-4CB2-AACB-DD636A2AB81D
P2860
XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@ast
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@en
type
label
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@ast
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@en
prefLabel
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@ast
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@en
P2093
P356
P1476
XPA A23G polymorphism is assoc ...... ed non-small cell lung cancer.
@en
P2093
Baoan Chen
Hongyan Cheng
Jiazhong Ji
Jifeng Feng
Shukui Qin
Xinchen Sun
P304
P356
10.1093/ABBS/GMP027
P577
2009-05-01T00:00:00Z